KORU Medical Systems Announces 2022 First Quarter Financial Results

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®

2022 Annual Meeting of Shareholders

May 6, 2022 • 8:00 am EDT

First Quarter 2022 Financial Results Conference Call

May 4, 2022 • 4:30 pm EDT